(Q37878397)

24 August 2017

1 reference

title

Bone health in multiple sclerosis (English)

1 reference

24 August 2017

0 references

J C Gibson

1

1 reference

24 August 2017

G D Summers

series ordinal

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

21 May 2011

1 reference

Osteoporosis International

24 August 2017

published in

1 reference

24 August 2017

volume

22

1 reference

24 August 2017

issue

12

1 reference

24 August 2017

page(s)

2935-2949

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-011-1644-8

24 August 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Fracture history and bone loss in patients with MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Risk of bone loss in men with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Favorable effect of immunomodulator therapy on bone mineral density in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Trabecular bone is more deteriorated in spinal cord injured versus estrogen-free postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Osteoporosis after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Reduced hip bone mineral density is related to physical fitness and leg lean mass in ambulatory individuals with chronic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Determinants of bone mineral density in immobilization: a study on hemiplegic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Injurious falls among middle aged and older adults with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Bilateral spontaneous periacetabular fracture: an unusual complication of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Incidence of fractures in a cohort of veterans with chronic multiple sclerosis or traumatic spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

A prospective study of physical trauma and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

The epidemiology of fractures in England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

A cross-sectional study of bone health in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Risk factors for falling among people aged 45 to 90 years with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Risks of falls in subjects with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Risk factors for falls among elderly persons living in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Effects of high doses of corticosteroids on bone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Oral corticosteroids and fracture risk: relationship to daily and cumulative doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Fracture risk with intermittent high-dose oral glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Immunomodulatory effects of Vitamin D in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Plasma osteopontin levels in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Beliefs, perceptions, and practices related to osteoporosis risk reduction among women with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

The transition from relapsing-remitting MS to irreversible disability: clinical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Evidence for a two-stage disability progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Cycling progressive resistance training for people with multiple sclerosis: a randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Resistance training improves muscle strength and functional capacity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

The impact of regular physical activity on fatigue, depression and quality of life in persons with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Falls in older people: epidemiology, risk factors and strategies for prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

How to select the doses of vitamin D in the management of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Renal physiology in elderly persons with severe immobility syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Falls, fractures, and osteoporosis after stroke: time to think about protection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

A case report: femoral fracture in a multiple sclerosis patient with vitamin d deficiency--a preventable injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1644-8

Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis

21 January 2018

1 reference

12 December 2020

Increased serum osteopontin is a risk factor for osteoporosis in menopausal women

1 reference

12 December 2020

Bone health in ambulatory individuals with multiple sclerosis: impact of physical activity, glucocorticoid use, and body composition.

1 reference

12 December 2020

Bone strength in multiple sclerosis: cortical midtibial speed-of-sound assessment

1 reference

12 December 2020

Effect of exercise training on walking mobility in multiple sclerosis: a meta-analysis

1 reference

12 December 2020

25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis

1 reference

12 December 2020

Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients

1 reference

12 December 2020

What affects your MS? Responses to an anonymous, Internet-based epidemiological survey

1 reference

12 December 2020

Unrecognised femoral fractures in patients with paraplegia due to multiple sclerosis

1 reference

12 December 2020

Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids

1 reference

12 December 2020

Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly

1 reference

12 December 2020

Bone status in multiple sclerosis: beyond corticosteroids

1 reference

12 December 2020

Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis

1 reference

12 December 2020

Can vitamin D supplementation prevent bone loss in persons with MS? A placebo-controlled trial

1 reference

12 December 2020

The effect of interferon beta 1B on bone mineral density in multiple sclerosis patients

1 reference

12 December 2020

Walking after stroke: does it matter? Changes in bone mineral density within the first 12 months after stroke. A longitudinal study

1 reference

12 December 2020

Relative influence of physical activity, muscle mass and strength on bone density

1 reference

12 December 2020

A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis

1 reference

12 December 2020

Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: a 12-month randomized prospective controlled study

1 reference

12 December 2020

Falls requiring medical attention among veterans with multiple sclerosis: a cohort study.

1 reference

12 December 2020

Relapses and progression of disability in multiple sclerosis

1 reference

12 December 2020

High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis

1 reference

12 December 2020

Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women

1 reference

12 December 2020

Preventive healthcare in women with multiple sclerosis

1 reference

12 December 2020

Fractures in multiple sclerosis

1 reference

12 December 2020

Body composition in ambulatory women with multiple sclerosis

1 reference

12 December 2020

1 reference

12 December 2020

Oropharyngeal dysphagia in multiple sclerosis

1 reference

12 December 2020

Osteoporosis in patients with paralysis after spinal cord injury. A cross sectional study in 46 male patients with dual-energy X-ray absorptiometry

1 reference

12 December 2020

Predicting accidental falls in people with multiple sclerosis — a longitudinal study

1 reference

12 December 2020

The role of osteopontin: a shared pathway in the pathogenesis of multiple sclerosis and osteoporosis?

1 reference

12 December 2020

Rate and types of fractures in corticosteroid-treated multiple sclerosis patients

1 reference

12 December 2020

Perceptions of women with multiple sclerosis about osteoporosis follow-up

1 reference

12 December 2020

Reduced bone mass and fat-free mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid Use

1 reference

12 December 2020

Falls by elderly people at home: prevalence and associated factors

1 reference

12 December 2020

10.1007/S00198-011-1644-8

Identifiers

DOI

1 reference

24 August 2017

1 reference